…of walking, as a risk factor for developing knee osteoarthritis (OA). Valgus thrust, or knock-knee alignment during walking, may also increase the risk of knee OA. Here, Chang et al…
Search Results for: osteoarthritis
Prevalence of osteoarthritis of the knee is high in Chinese population despite relative thinness
Prevelence of Osteoarthritis of the Knee is High in Chinese Population Despite Relative Thinness Osteoarthritis (OA) is a leading cause of disability among older persons in Western societies. Overweight has…
FDA Approves Valdecoxib (Bextra) for Treatment in Osteoarthritis and Rheumatoid Arthritis
FDA Approves Valdecoxib (Bextra™) for Treatment in Osteoarthritis and Rheumatoid Arthritis On November 19, the U.S. Food and Drug Administration (FDA) approved Bextra® (valdecoxib) for relief of the signs and…
Glucosamine Sulphate for the Treatment of Osteoarthritis News Summary from Johns Hopkins Arthritis
Glucosamine for the Treatment of Osteoarthritis Reginster et al (Lancet 357:251, 2001) conducted a double-blind, placebo-controlled trial to assess the long-term effects of glucosamine sulphate on the progression of structural…
Meloxicam (mobic) Receives FDA Approval for Osteoarthritis
Home > Arthritis News > 2000 Meloxicam (Mobic®) Receives FDA Approval Earlier this month, meloxicam (Mobic) received approval from the Food and Drug Administration (FDA) for use in osteoarthritis (OA)….
Study Finds No Treatment Benefit of Intra-Articular Anakinra in Knee Osteoarthritis
Anakinra (Kineret) Inflammatory cytokines, in particular IL-1, are elevated in the synovial fluid of patients with knee osteoarthritis (OA); however, their contribution to OA symptoms and damage are unclear. A…